|
Centre for Policy on Ageing | |
 | |
|
Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression | Author(s) | Daniel Keaton, Nathan Lamkin, Kristin A Cassidy |
Journal title | International Journal of Geriatric Psychiatry, vol 24, no 10, October 2009 |
Pages | pp 1087-1093 |
Source | http://www.interscience.wiley.com/journal/gps |
Keywords | Nutrition ; Vitamins ; Alternative medicine ; Usage [services] ; Depression ; Schizophrenia ; Cross sectional surveys ; United States of America. |
Annotation | Herbal and nutritional compounds (HNC) are widely used among geriatric populations with depression, however little data exists on HNC use in older populations with bipolar disorder. The goal of this American study was to evaluate orally-ingested HNC use in individuals with bipolar disorder and with major depression. This was a cross-sectional analysis of self-reported factual knowledge of HNC, individual perspective on efficacy and safety of HNC, patterns of HNC use, and discussion of HNC with health care providers in 50 older adults with bipolar disorder and 50 older adults with major depression. In this sample, approximately 30% of older individuals with depression or bipolar disorder used orally-ingested HNC. Over 40% of older adults believed HNC to be regulated by the Food and Drug Administration (FDA), and 14-20% preferred to take HNC compared to physician-prescribed psychotropic medications. Use of HNC was more common among older adults with bipolar disorder (44%) compared to older adults with major depression (16%, p=0.003). The majority of older adults with mood disorders (64%) had not discussed use of HNC with their treating physicians. Orally ingested HNC was used by nearly one in three older adults with mood disorders, and was more common among those with bipolar disorder compared to those with major depression. Most individuals did not discuss HNC use with their physicians. Clinicians need to assess for HNC use, particularly with respect to potential drug-drug interactions. (KJ/RH). |
Accession Number | CPA-100109212 A |
Classmark | CF: CFE: LK3: QLD: ENR: ELK: 3KB: 7T |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|